AOD-9604 Peptide Intelligence Monograph | FIME

Growth Hormone Fragment • Adipose Metabolism • Weight-Loss Claims • Evidence Reality

AOD-9604 is widely promoted as a “fat-burning peptide.” But what does the human evidence actually show?

The Founder’s Institute of Medicine & Education AOD-9604 Peptide Intelligence Monograph provides an evidence-based examination of this growth-hormone-derived peptide—from its compelling biological rationale and preclinical research to the human obesity trials that ultimately challenged the original therapeutic hypothesis.

Inside this monograph:

• What AOD-9604 is and how it relates to human growth hormone
• Proposed effects on lipolysis, lipogenesis, and fat oxidation
• Preclinical metabolic and adiposity research
• Human obesity and weight-loss clinical trials
• The pivotal clinical-development findings
• GH/IGF-1 considerations
• Safety and long-term evidence limitations
• Oral versus contemporary subcutaneous-use considerations
• Compounding and product-quality concerns
• FDA and regulatory context
• Emerging musculoskeletal and regenerative research
• FIME evidence grading and clinical interpretation

The Key Distinction

AOD-9604 has biological plausibility and meaningful human research behind it—but biological activity is not the same as demonstrated clinical efficacy.

The larger human clinical-development program did not establish AOD-9604 as an effective weight-loss therapy.

That distinction is exactly why this monograph exists.

FIME Evidence Perspective

Mechanistic Plausibility: Moderate
Preclinical Evidence: Moderate
Human Exposure: Moderate
Human Weight-Loss Efficacy: Low / Not Established
Long-Term Human Safety: Low
Evidence for Contemporary Subcutaneous Use: Very Low
FDA-Approved Therapeutic Indication: None

Evidence over hype. Science over claims. Integrity over revenue.

Version 1.0 Final

Published by the Founder’s Institute of Medicine & Education

For professional education, scientific review, and evidence-based discussion. Not individualized medical advice, a prescription, or a treatment protocol. AOD-9604 is not FDA-approved for obesity or weight loss.